1) CRM Shared Resource (CRM - Section 9.1.7): CRM is responsible for all centralized oversight andcoordination of protocol and data management activities of CCCWFU clinical research. CRM providescentralized patient registration, patient eligibility confirmation, drug monitoring and informatics services.CRM also provides operational and logistical oversight for the Protocol Review and Monitoring System(PRMS), Protocol Specific Research Support (PSRS) and Data and Safety Monitoring functions (DSM),ensuring alignment with CCCWFU scientific strategy and adherence to regulatory mandates. CRMprovides quality control oversight of data management, providing investigators assurance of high quality,efficient data management by trained and supervised staff.2) Protocol Review and Monitoring System (PRMS - Section 9.2): PRMS supports protocol developmentand protocol monitoring. PRMS evaluates all protocols for scientific merit and prioritizes protocolsbased on explicit CCCWFU priorities. PRMS also provides investigators with guidance in protocol writingand compliance with NCI and FDA regulatory guidelines. PRMS facilitates communications amongCCCWFU members, nurses, and staff, as well as with affiliate physicians and staff.3) Protocol Specific Research Support (PSRS Section 9.3): The PSRS functions include patientrecruitment, screening, compliance monitoring, and data management for institutional investigatorinitiatedCCCWFU feasibility and Phase I trials.4) Data and Safety Monitoring (DSM - Section 12.0): DSM identifies issues related to safety before andduring the course of studies. DSM reviews data trends related to safety and protocol milestones thatmight require protocol suspension or termination. Two committees in oversight of DSM functions, onefor phase I and II studies, and a separate committee for phase III studies. Support for these DSMfunctions is provided through personnel in the CRM shared resource. The CCCWFU has an NCIapprovedDSM plan.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA012197-32
Application #
7529769
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-11
Project End
2012-01-31
Budget Start
2007-07-11
Budget End
2008-01-31
Support Year
32
Fiscal Year
2007
Total Cost
$102,202
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Bonin, Keith; Smelser, Amanda; Moreno, Naike Salvador et al. (2018) Structured illumination to spatially map chromatin motions. J Biomed Opt 23:1-8
Rimkus, Tadas K; Carpenter, Richard L; Sirkisoon, Sherona et al. (2018) Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Res 78:2589-2600
Maggiore, Ronald J; Callahan, Kathryn E; Tooze, Janet A et al. (2018) Geriatrics fellowship training and the role of geriatricians in older adult cancer care: A survey of geriatrics fellowship directors. Gerontol Geriatr Educ 39:170-182
Rogers, LeAnn C; Davis, Ryan R; Said, Naveen et al. (2018) Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy. Redox Biol 15:380-386
Faig, Jennifer; Haughton, Michael; Taylor, Richard C et al. (2018) Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy. Am J Clin Oncol 41:432-440
Melvin, Ryan L; Xiao, Jiajie; Godwin, Ryan C et al. (2018) Visualizing correlated motion with HDBSCAN clustering. Protein Sci 27:62-75
Swanner, Jessica; Singh, Ravi (2018) Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models. Methods Mol Biol 1790:209-218
Nelson, Kimberly J; Perkins, Arden; Van Swearingen, Amanda E D et al. (2018) Experimentally Dissecting the Origins of Peroxiredoxin Catalysis. Antioxid Redox Signal 28:521-536
Feliz-Mosquea, Yismeilin R; Christensen, Ashley A; Wilson, Adam S et al. (2018) Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Res Treat 172:69-82
Holmila, Reetta J; Vance, Stephen A; Chen, Xiaofei et al. (2018) Mitochondria-targeted Probes for Imaging Protein Sulfenylation. Sci Rep 8:6635

Showing the most recent 10 out of 548 publications